Estimating the non-monetary burden of neurocysticercosis in mexico

PLoS Neglected Tropical Diseases

Volumn 6, Issue 2, 2012, Pages

  Bhattarai, Rachana ^a   Budke, Christine M ^a   Carabin, Hélène ^b   Proaño, Jefferson V ^c   Flores Rivera, Jose ^d   Corona, Teresa ^d   Ivanek, Renata ^a   Snowden, Karen F ^a   Flisser, Ana ^e  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

^d NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; DISABILITY; DISEASE ASSOCIATION; EPILEPSY; FEMALE; HEADACHE; HUMAN; INCIDENCE; INFANT; MALE; MEXICO; NEUROCYSTICERCOSIS; NEWBORN; PREMATURE MORTALITY; PRESCHOOL CHILD; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; SCHOOL CHILD; AGED; ANIMAL; DISABLED PERSON; MIDDLE AGED; MORTALITY; STATISTICS;

ADOLESCENT; ADULT; AGED; ANIMALS; CHILD; CHILD, PRESCHOOL; DISABLED PERSONS; EPILEPSY; FEMALE; HEADACHE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEXICO; MIDDLE AGED; NEUROCYSTICERCOSIS; YOUNG ADULT;

EID: 84857845185     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001521     Document Type: Article

References (28)

1. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, et al. (2010) A systematic review of the frequency of neurocysticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis; 4 (11): e870 Doi:10.1371/journal.pntd.0000870.
2. Cruz ME, Cruz I, Preux PM, Schantz P, Dumas M, (1995) Headache and cysticercosis in Ecuador, South America. Headache 35: 93-97.
3. Alarcon F, Vanormelingen K, Moncayo J, Vinan I, (1992) Cerebral cysticercosis as a risk factor for stroke in young and middle aged people. Stroke 23: 1563-1565.
4. Flisser A, (1994) Taeniasis and cysticercosis due to Taenia solium. Prog Clin Parasitol 4: 77-116.
5. Rajshekhar V, Joshi DD, Doanh NQ, van De N, Xiaonong Z, (2003) Taenia solium taeniosis/cysticercosis in Asia: epidemiology, impact and issues. Acta Trop 87: 53-60.
6. Zoli A, Shey-Njila O, Assana E, Nguekam JP, Dorny P, et al. (2003) Regional status, epidemiology and impact of Taenia solium cysticercosis in Western and Central Africa. Acta Trop 87: 35-42.
7. Flisser A, Sarti E, Lightowlers M, Schantz P, (2003) Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. Acta Trop 87: 43-51.
8. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J, (1990) Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 150: 325-327.
9. Carabin H, Krecek RC, Cowan LD, Michael L, Foyaca-Sibat H, et al. (2006) Estimation of the cost of Taenia solium cysticercosis in Eastern Cape Province, South Africa. Trop Med Int Health 11: 906-916.
10. Praet N, Speybroeck N, Manzanedo R, Berkvens D, Nsame Nforninwe D, et al. (2009) The Disease Burden of Taenia solium Cysticercosis in Cameroon. PLoS Negl Trop Dis 3: e406.
11. WHO GBD. Available: http://www.who.int/topics/global_burden_of_disease/en/. Accessed 08 April 2011.
12. Bhattarai R, Budke CM, Carabin H, Proaño JV, Flores-Rivera J, et al. (2011) Quality of life in patients with neurocysticercosis in Mexico. Am J Trop Med Hyg 84: 782-786.
13. UN Data (2010) Available: http://data.un.org/Data.aspx?d=POP&f=tableCode:22 Accessed 08 April 2011.
14. Morales J, Martinez JJ, Rosetti M, Fleury A, Maza V, et al. (2008) Spatial distribution of Taenia solium porcine cysticercosis within a rural area of Mexico. PLoS Negl Trop Dis 2: e284.
15. Commission on Epidemiology and Prognosis, International League Against Epilepsy (1993) Guidelines for epidemiologic studies on epilepsy. Epilepsia 34: 592-596.
16. Quet F, Preux PM, Huerta M, Ramirez R, Abad T, et al. (2011) Determining the burden of neurological disorders in populations living in tropical areas: who would be questioned? Lessons from a Mexican rural community. Neuroepidemiology 36: 194-203.
17. Burneo JG, Tellez-Zenteno J, Wiebe S, (2005) Understanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidence. Epilepsy Res 66: 63-74.
18. Rajshekhar V, Raghava MV, Prabhakaran V, Oommen A, Muliyil J, (2006) Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology 67: 2135-2139.
19. World development indicators. Washington, DC: The World Bank; 2006.
20. Meyer AC, Dua T, Ma J, Saxena S, Birbeck G, (2010) Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 88: 260-266.
21. Murray CJL, Lopez AD, (1996) The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Disease, Injuries, and Risk Factors in 1990 and Projected to 2020 Cambridge, MA Harvard University Press.
22. Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian YJ, et al. (2011) Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5: e1152.
23. Kurtz Z, Tookey P, Ross E, (1998) Epilepsy in young people: 23 year follow up of the British national child development study. BMJ 316: 339-342.
24. Lipton RB, Scher AI, Steiner TJ, Bigal ME, Kolodner K, et al. (2003) Patterns of health care utilization for migraine in England and in the United States. Neurology 60: 441-448.
25. Morillo LE, Alarcon F, Aranaga N, Aulet S, Chapman E, et al. (2005) Prevalence of migraine in Latin America. Headache 45: 106-117.
26. Murray CJ, (1994) Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 72: 429-445.
27. Leonardi M, Mathers CD, (2000) "Global Burden of Migraine in the Year 2000: Summary of Methods and Data Sources" GBD 2000 Working Paper, World Health Organization, Geneva. http://www.who.int/healthinfo/statistics/bod_migraine.pdf. Accessed 15 April 2011.
28. WHO (2004) GBD. Available: http://apps.who.int/ghodata/ _disease/en/. Accessed 15 April 2011.